Protagenic Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Protagenic Therapeutics Inc
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
/ 
Frequently asked questions
To buy Protagenic Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Protagenic Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Protagenic Therapeutics Inc is PTIX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Protagenic Therapeutics Inc has its primary listing on NASDAQ (Small cap). You can trade Protagenic Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Protagenic Therapeutics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Protagenic Therapeutics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Protagenic Therapeutics Inc .